Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Biomedicine & Pharmacotherapy, 2025
Optimizing mesenchymal stromal cells priming strategies for tailored effects on the secretome

González-Rodríguez Y., Casado-Santos A., González-Cubero E. et al.

Olink Target 48Technical StudiesTechnical EvaluationCell Culture Supernatant

World Journal of Psychiatry, 2025
Clinical manifestations of anxiety and depression in sepsis-associated encephalopathy and multi-omics identification of cluster of differentiation 38 as an early biomarker

Wu C., Zhu H., Sun Y. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Nature Aging, 2025
The geroprotectors trametinib and rapamycin combine additively to extend mouse healthspan and lifespan

Gkioni L., Nespital T., Baghdadi M. et al.

Olink Target 96 MouseAgingPathophysiologyMouse Plasma

Diabetology & Metabolic Syndrome, 2025
Decoding the impact of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist on cardiometabolic health: inflammatory mediators at the focus

Cheng F., Niu X., Wang Y. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

PLOS One, 2025
Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions

Poorbaugh J., Sims J., Zhang L. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

eBioMedicine, 2025
Radiomic and proteomic signatures of body mass index on brain ageing and Alzheimer's-like patterns of brain atrophy

Anagnostakis F., Kokkorakis M., Walker K. et al.

Olink Explore 3072/384Metabolic DiseasesNeurologyPathophysiologyPlasma

Diabetology & Metabolic Syndrome, 2025
Spontaneous brain activity in patients with type 2 diabetes: linking serum neuroproteins to cognitive ability

Zhang Z., Wang W., Yang X. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPatient StratificationSerum

International Journal of Biological Macromolecules, 2025
Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study

Wang J., Zhang P., Yuan J. et al.

Olink Target 96OncologyGynecologyPathophysiologyPlasma

Advanced Science, 2025
Colorectal Cancer Cells–Derived Exosomal PIK3CA Mutation DNA Promotes Tumor Metastasis by Activating Fibroblast and Affecting Tumor Metastatic Microenvironment

Wang R., Li W., Lv Y. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Obesity Surgery, 2025
Changes in Inflammatory Markers Following Bariatric Surgery and the Impact of the Surgical Procedure: A 12-Month Longitudinal Study

Jensen R., Thuesen A., Huang Y. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Scientific Reports, 2025
Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients

Zhou M., Zhang W., Dang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologyPatient StratificationPlasma

Liver Cancer, 2025
Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial

Zang M., Li Q., Hu X. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationSerum

Nature Communications, 2025
Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk

Zalesky A., Tian Y., Ferrucci L. et al.

Olink Explore 3072/384CVDAgingPathophysiologyPlasma

Thrombosis Journal, 2025
Therapeutic targets for venous thromboemblism: proteome-wide mendelian randomization and colocalization analyses

Li X., Yang C., Zhou M. et al.

Olink Explore 3072/384HematologyPathophysiologyPlasma

Infection, 2025
Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection

Chang C., Ma Z., Ren W. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Journal of Cardiac Failure, 2025
The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring

de Jong M., Allach Y., Kamar S. et al.

Olink Target 96CVDPathophysiologyPlasma

Med, 2025
Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality

Le T., van Abeelen K., Ardiansyah E. et al.

Olink Target 96Infectious DiseasesPathophysiologyCSF

Nature Communications, 2025
The health impacts and genetic architecture of food liking in cardio-metabolic diseases

Jiang W., Wang H., Geng Y. et al.

Olink Explore 3072/384CVDNutritional SciencePathophysiologyPlasma

Signal Transduction and Targeted Therapy, 2025
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Xie M., Bao M., Dong X. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma

European Neuropsychopharmacology, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis

Oliva V., Possidente C., Fanelli G. et al.

Olink Target 96NeurologyPathophysiologyPlasma

3478 publications